Zedsen Limited Public Funding

Awaiting Public Project Summary

In 2022 2.3M people were diagnosed with breast cancer (BC), globally, with roughly 670,000 deaths. In the five-year period before this, there were 7.8M cases, making it the most prevalent cancer globally. Current breast cancer screening techniques in the UK are imperfect, expensive, painful, subject to operator variability, fail to work in dense breast tissue and emit ionising radiation. This disproportionately affects younger women, women of colour and women from impoverished backgrounds. Zedsen has created a novel scanner that will improve early cancer diagnosis, whilst reducing costs and saving lives. Zedsen aims to address these current diagnostic challenges with its non-invasive, sensing technology to detect breast cancer without emitting ionising radiation whilst being comfortable for patients. Zedsen uses its pioneering, patent-protected scanners to evaluate changes in the electrical properties of breast tissue. This has the potential to revolutionise breast cancer diagnosis by providing easy-to-understand, quantitative information to allow doctors to exclude cancer with confidence. Our mission is to improve access to cancer-care on a global level, with our first target being breast cancer. The Zedsen device has the potential to deliver diagnoses to many other cancers. We want to deliver accurate, affordable and clinically actionable healthcare to all.

Although the biggest cause of premature female death, if diagnosed early breast cancer is curable. Zedsen is therefore developing a unique, wearable device which contains completely harmless next-generation sensors. It will be low cost, completely safe and will be both quick and simple to use. A smart phone will remind the owner once a month to wear the device and conduct a scan. If any abnormality is detected it can then be dealt with rapidly and simply. This highly innovative technological breakthrough from Zedsen, now being part funded by Innovate UK, represents yet another UK healthcare world first.

Medical imaging has an important role in every medical setting as effective decisions depend on a correct diagnosis. However current technology (i.e. x-ray & MRI) is expensive, and requires strict safety measures and compatible equipment to avoid serious injury to patients and staff from radiation. Zedsen have developed a portable sensor that can overcome these limitations by utilising a static electrical energy field to create real time 3D diagnostic images

Cranfield University: Cranfield is the postgraduate specialist for research and teaching in science, engineering, technology and management. As one of the top five research-intensive universities in the UK, we are making a significant difference in the real world and we do this by working in partnership with some of the world's greatest organisations.